• 1. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 2. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

Introduction to (5-Methanesulfonylthiophen-2-yl)methanamine Hydrochloride (CAS No. 503469-57-6)

(5-Methanesulfonylthiophen-2-yl)methanamine Hydrochloride, identified by the CAS number 503469-57-6, is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound belongs to the class of amine derivatives, featuring a thiophene core modified with a methanesulfonyl group and an amine functional group. The hydrochloride salt form enhances its solubility and stability, making it a valuable intermediate in synthetic chemistry and a potential candidate for various biological applications.

The structural integrity of (5-Methanesulfonylthiophen-2-yl)methanamine Hydrochloride is characterized by its aromatic thiophene ring, which is a common motif in many biologically active molecules. The presence of the methanesulfonyl group at the 5-position and the amine group at the 2-position introduces unique electronic and steric properties that can influence its interactions with biological targets. This compound's design allows for modifications that can fine-tune its pharmacological profile, making it a versatile tool in drug discovery.

Recent advancements in medicinal chemistry have highlighted the importance of heterocyclic compounds in developing novel therapeutic agents. The thiophene scaffold, in particular, has been extensively studied for its role in antimicrobial, anti-inflammatory, and anticancer applications. (5-Methanesulfonylthiophen-2-yl)methanamine Hydrochloride leverages these properties, offering a promising platform for further exploration.

In vitro studies have begun to uncover the potential of (5-Methanesulfonylthiophen-2-yl)methanamine Hydrochloride as an intermediate in synthesizing more complex molecules. Its ability to serve as a precursor for larger peptides and proteins makes it particularly interesting for researchers working on enzyme inhibition and receptor binding studies. The hydrochloride form ensures that the compound remains stable under various experimental conditions, facilitating its use in high-throughput screening assays.

The synthesis of (5-Methanesulfonylthiophen-2-yl)methanamine Hydrochloride involves multi-step organic reactions, including sulfonylation and amination processes. These synthetic routes are optimized to maximize yield and purity, ensuring that researchers have access to high-quality material for their studies. The compound's molecular structure allows for further functionalization, enabling the creation of derivatives with tailored properties.

One of the most exciting areas of research involving (5-Methanesulfonylthiophen-2-yl)methanamine Hydrochloride is its potential application in targeted therapy. By modifying its structure, researchers can develop molecules that selectively interact with specific biological pathways. This approach is particularly relevant in oncology, where precision medicine aims to address the unique molecular profiles of cancer cells. Preliminary data suggest that derivatives of this compound may exhibit inhibitory effects on certain kinases and other enzymes overexpressed in tumor cells.

The pharmacokinetic properties of (5-Methanesulfonylthiophen-2-yl)methanamine Hydrochloride are also under investigation. Understanding how the compound is absorbed, distributed, metabolized, and excreted (ADME) is crucial for determining its suitability for clinical use. Initial studies indicate that the hydrochloride salt has good oral bioavailability and moderate metabolic stability, suggesting potential for further development into an oral therapeutic agent.

In conclusion, (5-Methanesulfonylthiophen-2-yl)methanamine Hydrochloride (CAS No. 503469-57-6) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and promising biological activity make it a valuable asset in drug discovery efforts. As research continues to uncover new applications and synthetic methodologies, this compound is poised to play a crucial role in the development of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)